Shares of CVS Health are trading higher Thursday afternoon. The stock is climbing after a GOP healthcare bill hit a roadblock in the Senate.

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it overcharged Medicare for prescription drugs.

While the journey toward AI-driven healthcare is still in its early stages, the impact of these technologies is already being felt.

The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it struggles with recent challenges, an analyst said.

This episode features Peter D. Banko, President and CEO of Baystate Health, sharing how the system is advancing financial resilience, culture and engagement, and access to care.

"We are excited to work with Visium to pioneer technologies that will empower our healthcare systems," said Michael Ofori, CEO of Investor Hub.

A significant investment is set to transform Jefferson County with the establishment of a 14,000-square-foot Community Innovation Center at Indian Creek Middle ...

Zyter|TruCare Appoints New CEO to Drive Agentic AI-Powered Transformation in Healthcare Sundar Subramanian to lead new chapter of transformational, AI-orchestrated population health management ...

Visium Technologies and Investor Hub Co. Ltd Sign Strategic MOU to Advance AI‑Powered Healthcare Solutions Across West Africa ...

The Whatcom Transportation Authority wants to transform the space into another downtown transit station.